Table 2: Ruggedness (% Recovery ± SD)

Concentration Levels*

% Recovery ± SD

Day

Cytosine

Thymine

Lamivudine

Zidovudine

Nevirapine

Low

97.29 ± 1.27

104.79 ± 1.46

99.97 ± 0.07

103.21 ± 1.71

106.69 ± 1.24

1

Med

98.97 ± 0.37

99.35 ± 0.28

99.87 ± 0.01

100.84 ± 0.06

96.51 ± 0.16

High

99.42 ± 0.63

101.58 ± 0.24

100.52 ± 0.00

99.86 ± 0.01

98.95 ± 0.05

 

 

 

 

 

 

 

Low

101.79 ± 1.00

107.28 ± 2.14

104.14 ± 0.44

97.69 ± 0.77

110.65 ± 1.73

2

Med

102.30 ± 0.13

98.91 ± 0.30

99.01 ± 0.02

102.39 ± 0.02

99.68 ± 0.03

High

103.17 ± 0.65

97.21 ± 0.19

98.26 ± 0.03

101.72 ± 0.03

98.86 ± 0.04

 

 

 

 

 

 

 

Low

101.67 ± 0.73

112.00 ± 0.51

97.47 ± 0.99

94.17 ± 2.74

109.74 ± 0.77

3

Med

100.57 ± 0.05

98.63 ± 0.47

102.63 ± 0.13

103.80 ± 0.05

102.96 ± 0.06

High

101.16 ± 0.20

100.29 ± 0.18

99.47 ± 1.83

98.59 ± 0.05

102.94 ± 0.02

 * All the experiment at different concentration levels were performed in triplicates.

Christianah Adeyeye et al.Journal of Pharmaceutical Technology and Drug Research  2012 1:4DOI : 10.7243/2050-120X-1-4